Evidence map›Paper›PMID 38659878›Full record

ArticleResearch square2024

Clinical, pathologic and molecular findings in 2 Rottweiler littermates with appendicular osteosarcoma.

Kate I Silver, Joshua D Mannheimer, Corey Saba, William P D Hendricks, Guannan Wang, Kenneth Day, Manisha Warrier, Jessica A Beck, Christina Mazcko, Amy K LeBlanc

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kate I SilverNational Cancer Institute, NIH.
Joshua D MannheimerNational Cancer Institute, NIH.
Corey SabaUniversity of Georgia.
William P D HendricksVidium Animal Health, A Subsidiary of The Translational Genomics Research Institute (TGen).
Guannan WangVidium Animal Health, A Subsidiary of The Translational Genomics Research Institute (TGen).
Kenneth DayVidium Animal Health, A Subsidiary of The Translational Genomics Research Institute (TGen).
Manisha WarrierVidium Animal Health, A Subsidiary of The Translational Genomics Research Institute (TGen).
Jessica A BeckNational Cancer Institute, NIH.
Christina MazckoNational Cancer Institute, NIH.
Amy K LeBlancNational Cancer Institute, NIH.

Funding

COP LaboratoryZIABC011692 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEBLANC, AMY · 2016 to 2025
$15.5M
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGSZ01BC006161 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POMMIER, YVES · 1996 to 2008
$1.5M
Comparative Oncology Trials ConsortiumZIGBC011689 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEBLANC, AMY · 2016 to 2025
$859k
Intramural NIH HHS Z01 BC006161
6 · The paper itself

Abstract

Appendicular osteosarcoma was diagnosed and treated in a pair of littermate Rottweiler dogs, resulting in distinctly different clinical outcomes despite similar therapy within the context of a prospective, randomized clinical trial (NCI-COTC021/022). Histopathology, immunohistochemistry, mRNA sequencing, and targeted DNA hotspot sequencing techniques were applied to both dogs' tumors to define factors that could underpin their differential response to treatment. We describe the comparison of their clinical, histologic and molecular features, as well as those from a companion cohort of Rottweiler dogs, providing new insight into potential prognostic biomarkers for canine osteosarcoma.

Indexed as

caninegenomicsOsteosarcomaRottweiler

Identifiers

PMID38659878
PMCPMC11042397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.